These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37343824)

  • 1. Patterns of rescue and maintenance therapy claims surrounding a clinical encounter for an asthma exacerbation.
    Lanz MJ; Gilbert IA; Gandhi HN; Pollack M; Tkacz JP; Lugogo NL
    Ann Allergy Asthma Immunol; 2023 Oct; 131(4):458-465.e1. PubMed ID: 37343824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of Rescue and Maintenance Medication Claims Surrounding an Asthma Exacerbation in Patients Treated as Intermittent or Mild Persistent Asthma.
    Lanz MJ; Pollack M; Gilbert IA; Gandhi HN; Tkacz JP; Lugogo NL
    J Asthma Allergy; 2024; 17():871-877. PubMed ID: 39296429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-world patterns and implications of short-acting β
    Lugogo N; Gilbert I; Tkacz J; Gandhi H; Goshi N; Lanz MJ
    Ann Allergy Asthma Immunol; 2021 Jun; 126(6):681-689.e1. PubMed ID: 33515710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-Acting Beta-2-Agonist Exposure and Severe Asthma Exacerbations: SABINA Findings From Europe and North America.
    Quint JK; Arnetorp S; Kocks JWH; Kupczyk M; Nuevo J; Plaza V; Cabrera C; Raherison-Semjen C; Walker B; Penz E; Gilbert I; Lugogo NL; van der Valk RJP;
    J Allergy Clin Immunol Pract; 2022 Sep; 10(9):2297-2309.e10. PubMed ID: 35364341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of short-acting bronchodilators and cost burden of asthma across Global Initiative for Asthma-based severity levels: Insights from a large US commercial and managed Medicaid population.
    Pollack M; Gandhi H; Tkacz J; Lanz M; Lugogo N; Gilbert I
    J Manag Care Spec Pharm; 2022 Aug; 28(8):881-891. PubMed ID: 35708342
    [No Abstract]   [Full Text] [Related]  

  • 6. Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes.
    Reddel HK; Bacharier LB; Bateman ED; Brightling CE; Brusselle GG; Buhl R; Cruz AA; Duijts L; Drazen JM; FitzGerald JM; Fleming LJ; Inoue H; Ko FW; Krishnan JA; Levy ML; Lin J; Mortimer K; Pitrez PM; Sheikh A; Yorgancioglu AA; Boulet LP
    J Allergy Clin Immunol Pract; 2022 Jan; 10(1S):S1-S18. PubMed ID: 34718211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.
    Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asthma Controller Medication Adherence, Risk of Exacerbation, and Use of Rescue Agents Among Texas Medicaid Patients with Persistent Asthma.
    Makhinova T; Barner JC; Richards KM; Rascati KL
    J Manag Care Spec Pharm; 2015 Dec; 21(12):1124-32. PubMed ID: 26679962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled Corticosteroid-Containing Treatment Escalation and Outcomes for Patients with Asthma in a U.S. Health Care Organization.
    Bengtson LGS; Yu Y; Wang W; Cao F; Hulbert EM; Wolbeck R; Elliott CA; Buikema AR
    J Manag Care Spec Pharm; 2017 Nov; 23(11):1149-1159. PubMed ID: 29083972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and children.
    Cates CJ; Karner C
    Cochrane Database Syst Rev; 2013 Apr; 2013(4):CD007313. PubMed ID: 23633340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
    Blanchette CM; Culler SD; Ershoff D; Gutierrez B
    Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes.
    Reddel HK; Bacharier LB; Bateman ED; Brightling CE; Brusselle GG; Buhl R; Cruz AA; Duijts L; Drazen JM; FitzGerald JM; Fleming LJ; Inoue H; Ko FW; Krishnan JA; Levy ML; Lin J; Mortimer K; Pitrez PM; Sheikh A; Yorgancioglu AA; Boulet LP
    Respirology; 2022 Jan; 27(1):14-35. PubMed ID: 34668278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined inhaled beta-agonist and anticholinergic agents for emergency management in adults with asthma.
    Kirkland SW; Vandenberghe C; Voaklander B; Nikel T; Campbell S; Rowe BH
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD001284. PubMed ID: 28076656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Paradigm Shift for Asthma Care.
    Lugogo N; Skolnik N; Jiang Y
    J Fam Pract; 2022 Jul; 71(6 Suppl):S1-S10. PubMed ID: 35960943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-acting β2-agonist prescriptions in patients with asthma: findings from the South Korean cohort of SABINA III.
    Yoo KH; Kim SH; Kim SH; Moon JY; Park HW; Chang YS; Beekman MJHI
    Korean J Intern Med; 2024 Jan; 39(1):123-136. PubMed ID: 38057957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Budesonide-Formoterol for Maintenance and Reliever Therapy Among Patients With Poorly Controlled Asthma: A Systematic Review and Meta-analysis.
    Beasley R; Harrison T; Peterson S; Gustafson P; Hamblin A; Bengtsson T; Fagerås M
    JAMA Netw Open; 2022 Mar; 5(3):e220615. PubMed ID: 35230437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daily vs. intermittent inhaled corticosteroids for recurrent wheezing and mild persistent asthma: a systematic review with meta-analysis.
    Rodrigo GJ; Castro-Rodríguez JA
    Respir Med; 2013 Aug; 107(8):1133-40. PubMed ID: 23769720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quarterly assessment of short-acting beta(2)-adrenergic agonist use as a predictor of subsequent health care use for asthmatic patients in the United States.
    Silver HS; Blanchette CM; Kamble S; Petersen H; Letter M; Meddis D; Gutierrez B
    J Asthma; 2010 Aug; 47(6):660-6. PubMed ID: 20615167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination fixed-dose β agonist and steroid inhaler as required for adults or children with mild asthma: a Cochrane systematic review.
    Crossingham I; Turner S; Ramakrishnan S; Fries A; Gowell M; Yasmin F; Richardson R; Webb P; O'Boyle E; Hinks TSC
    BMJ Evid Based Med; 2022 Jun; 27(3):178-184. PubMed ID: 34282031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-acting β
    Theerakittikul T; Nakwan N; Niyompattama A; Siriphan P; Beekman MJHI
    J Asthma; 2023 Dec; 60(12):2177-2188. PubMed ID: 37405933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.